Bronson Crouch is the Chief Executive Officer of Instil Bio, a biotechnology company focused on innovative cancer treatments. He has a solid academic background with an MBA from a well-regarded institution, which shows he knows how to manage and lead....
Bronson Crouch is the Chief Executive Officer of Instil Bio, a biotechnology company focused on innovative cancer treatments. He has a solid academic background with an MBA from a well-regarded institution, which shows he knows how to manage and lead. Born in 1978, Bronson has been with Instil Bio since its early days, having played a role in pivotal financing rounds that helped shape the company's future. His leadership has led to significant salary adjustments, reflecting the company’s growth and challenges in achieving corporate goals. Interestingly, Bronson holds a substantial amount of stock in the company, suggesting a strong personal investment in its success. In 2023, he received a total compensation of over $1.1 million, largely attributed to incentives aimed at keeping key talent in the company. His tenure has seen fluctuations in his personal financial portfolio, with notable drops in stock value amidst market challenges. Bronson's strategy focuses on attracting top talent and aligning executive pay with company performance, which is crucial in the competitive biotech field.